Sentry Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,368
Closed -$448K 30
2025
Q4
$448K Hold
1,368
0.29% 61
2025
Q3
$403K Sell
1,368
-356
-21% -$103K 0.27% 71
2025
Q2
$512K Hold
1,724
0.28% 67
2025
Q1
$499K Sell
1,724
-515
-23% -$152K 0.34% 55
2024
Q4
$584K Sell
2,239
-364
-14% -$108K 0.28% 76
2024
Q3
$839K Hold
2,603
0.35% 59
2024
Q2
$813K Buy
2,603
+1,413
+119% +$415K 0.36% 52
2024
Q1
$338K Sell
1,190
-1,616
-58% -$473K 0.13% 167
2023
Q4
$808K Sell
2,806
-301
-10% -$82K 0.35% 55
2023
Q3
$835K Sell
3,107
-611
-16% -$152K 0.4% 46
2023
Q2
$825K Hold
3,718
0.31% 76
2023
Q1
$899K Sell
3,718
-14
-0.4% -$3.44K 0.37% 61
2022
Q4
$980K Buy
3,732
+81
+2% +$21.7K 0.43% 49
2022
Q3
$823K Hold
3,651
0.39% 51
2022
Q2
$888K Sell
3,651
-842
-19% -$206K 0.4% 52
2022
Q1
$1.09M Sell
4,493
-788
-15% -$181K 0.35% 62
2021
Q4
$1.19M Buy
5,281
+507
+11% +$107K 0.31% 79
2021
Q3
$1.01M Sell
4,774
-1,454
-23% -$335K 0.3% 81
2021
Q2
$1.52M Hold
6,228
0.39% 62
2021
Q1
$1.55M Sell
6,228
-29,800
-83% -$7.11M 0.43% 50
2020
Q4
$8.28M Sell
36,028
-1,802
-5% -$415K 0.42% 58
2020
Q3
$9.62M Buy
37,830
+3,518
+10% +$872K 0.53% 41
2020
Q2
$8.09M Sell
34,312
-3,625
-10% -$827K 0.49% 43
2020
Q1
$7.69M Sell
37,937
-34
-0.1% -$7.43K 0.57% 43
2019
Q4
$9.15M Hold
37,971
0.55% 38
2019
Q3
$7.35M Hold
37,971
0.48% 47
2019
Q2
$7M Sell
37,971
-17,303
-31% -$3.1M 0.46% 48
2019
Q1
$10.5M Sell
55,274
-10,176
-16% -$1.94M 0.73% 27
2018
Q4
$12.7M Sell
65,450
-2,448
-4% -$478K 0.92% 20
2018
Q3
$14.1M Buy
67,898
+3,344
+5% +$659K 0.86% 19
2018
Q2
$11.9M Sell
64,554
-6,691
-9% -$1.18M 0.78% 23
2018
Q1
$12.1M Sell
71,245
-5,701
-7% -$1.05M 0.74% 26
2017
Q4
$13.4M Buy
76,946
+475
+0.6% +$84.1K 0.73% 29
2017
Q3
$14.3M Sell
76,471
-39
-0.1% -$6.91K 0.53% 32
2017
Q2
$13.2M Buy
76,510
+867
+1% +$141K 0.52% 34
2017
Q1
$12.4M Sell
75,643
-3,299
-4% -$548K 0.51% 37
2016
Q4
$11.5M Buy
78,942
+1,363
+2% +$205K 0.48% 40
2016
Q3
$12.9M Buy
77,579
+7,209
+10% +$1.22M 0.56% 31
2016
Q2
$10.7M Buy
70,370
+619
+0.9% +$96.2K 0.47% 38
2016
Q1
$10.5M Hold
69,751
0.47% 39
2015
Q4
$11.3M Sell
69,751
-15,992
-19% -$2.51M 0.52% 37
2015
Q3
$11.9M Buy
85,743
+7,397
+9% +$1.17M 0.59% 28
2015
Q2
$12M Buy
78,346
+6,970
+10% +$1.12M 0.56% 30
2015
Q1
$11.4M Buy
71,376
+27,218
+62% +$4.29M 0.54% 30
2014
Q4
$7.03M Sell
44,158
-2,080
-4% -$324K 0.34% 54
2014
Q3
$6.5M Buy
46,238
+201
+0.4% +$26.2K 0.33% 51
2014
Q2
$5.45M Buy
46,037
+2,494
+6% +$289K 0.28% 62
2014
Q1
$5.37M Hold
43,543
0.28% 56
2013
Q4
$4.97M Sell
43,543
-2,300
-5% -$262K 0.27% 62
2013
Q3
$5.13M Buy
45,843
+31,576
+221% +$3.42M 0.3% 51
2013
Q2
$1.41M Buy
+14,267
New +$1.48M 0.08% 129

Other funds holding AMGN

Sentry Investment Management's AMGN Position: Q1 2026 in Review

Sentry Investment Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,368 shares — an estimated $448K sold.

Sentry Investment Management first reported a position in AMGN in Q2 2013 and held it in 51 quarters. The position peaked at $14.3M in Q3 2017. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sentry Investment Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 1,368 Amgen shares in Q1 2026, an estimated $448K.
  • Sentry Investment Management first reported a position in Amgen in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Amgen position peaked at $14.3M in Q3 2017.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.